Showing results (741-750 of 855) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|October 14, 2017
The Prognostic Significance of Measurable ("Minimal") Residual Disease in Acute Myeloid LeukemiaFrancesco Buccisano, Christopher S Hourigan, Roland B WalterCurrent Hematologic Malignancy Reports|October 10, 2015
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell ProjectMonica Bellei, Chadi Nabhan, Emanuela Anna Pesce, et al.Current Hematologic Malignancy Reports|August 7, 2017
Targeting Immune System Alterations in Hodgkin LymphomaNatalie S Grover, Barbara SavoldoCurrent Hematologic Malignancy Reports|September 16, 2017
Computational Modeling and Treatment Identification in the Myelodysplastic SyndromesLeylah M Drusbosky, Christopher R CogleCurrent Hematologic Malignancy Reports|February 5, 2018
The Future of Combination Therapies for Peripheral T Cell Lymphoma (PTCL)Helen Ma, Ardy Davarifar, Jennifer E AmengualCurrent Hematologic Malignancy Reports|February 7, 2018
Managing the Mental Distress of the Hematopoietic Stem Cell Transplant (HSCT) Patient: a Focus on DeliriumJoseph BubaloCurrent Hematologic Malignancy Reports|February 10, 2018
Novel Therapies for Older Adults With Acute Lymphoblastic LeukemiaNicholas J Short, Hagop Kantarjian, Elias Jabbour, et al.Current Hematologic Malignancy Reports|January 15, 2019
Graft Versus Host Disease Clinical Trials: Is it Time for Patients Centered Outcomes to Be the Primary Objective?Bronwen E ShawCurrent Hematologic Malignancy Reports|July 28, 2010
Stem cell transplantation in childhood non-Hodgkin's lymphomasFatma V Okur, Robert KranceCurrent Hematologic Malignancy Reports|May 22, 2010
Does rituximab have a place in treating classic hodgkin lymphoma?Yasuhiro Oki, Anas YounesPageof 86